No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Pertuzumab plus trastuzumab significantly improves survival in metastatic breast cancer

byTeddy Guo

March 23, 2022

in StudyGraphics

Reading Time: 1 min read

Vaccine booster after Johnson & Johnson-Janssen priming are safe and immunogenic

RelatedReports

The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Celebrity diagnoses spur screenings, athlete mental-health push, reality-TV heart lesson, and a sitcom PSA wave

July 2, 2025

Chronic Disease

Breast cancer survivors may have a lower risk of Alzheimer’s dementia

July 2, 2025

3D mammography (tomosynthesis) enhances accuracy of breast cancer screening

Chronic Disease

Abbreviated MRI is superior to whole-breast ultrasound for detection of cancer in dense breasts

June 25, 2025

StudyGraphics

#VisualAbstract: Tarlatamab Improves Survival in Small-Cell Lung Cancer after Platinum-Based Chemotherapy

June 19, 2025

Large proportion of late preterm infants and older admitted to the NICU

Neonatal hypoglycemia not significantly associated with lower educational achievement during childhood

Multiple variables related to physical activity levels in preschool children

Cardiosphere-derived cell therapy slows disease progression in Duchenne muscular dystrophy

Wellness Check: Spirituality

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports